1. Home
  2. NXL vs INHD Comparison

NXL vs INHD Comparison

Compare NXL & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • INHD
  • Stock Information
  • Founded
  • NXL 2010
  • INHD 2019
  • Country
  • NXL United States
  • INHD United States
  • Employees
  • NXL N/A
  • INHD N/A
  • Industry
  • NXL Medical Specialities
  • INHD
  • Sector
  • NXL Health Care
  • INHD
  • Exchange
  • NXL Nasdaq
  • INHD Nasdaq
  • Market Cap
  • NXL 21.0M
  • INHD 19.8M
  • IPO Year
  • NXL 2022
  • INHD 2023
  • Fundamental
  • Price
  • NXL $0.95
  • INHD $1.31
  • Analyst Decision
  • NXL Strong Buy
  • INHD
  • Analyst Count
  • NXL 1
  • INHD 0
  • Target Price
  • NXL $5.00
  • INHD N/A
  • AVG Volume (30 Days)
  • NXL 87.1K
  • INHD 931.4K
  • Earning Date
  • NXL 08-07-2025
  • INHD 08-11-2025
  • Dividend Yield
  • NXL N/A
  • INHD N/A
  • EPS Growth
  • NXL N/A
  • INHD N/A
  • EPS
  • NXL N/A
  • INHD N/A
  • Revenue
  • NXL $131,065.00
  • INHD $1,559,595.00
  • Revenue This Year
  • NXL $79.59
  • INHD N/A
  • Revenue Next Year
  • NXL $334.65
  • INHD N/A
  • P/E Ratio
  • NXL N/A
  • INHD N/A
  • Revenue Growth
  • NXL N/A
  • INHD 287.83
  • 52 Week Low
  • NXL $0.59
  • INHD $1.11
  • 52 Week High
  • NXL $4.49
  • INHD $19.78
  • Technical
  • Relative Strength Index (RSI)
  • NXL 30.94
  • INHD 40.83
  • Support Level
  • NXL $0.89
  • INHD $1.18
  • Resistance Level
  • NXL $1.03
  • INHD $1.52
  • Average True Range (ATR)
  • NXL 0.08
  • INHD 0.16
  • MACD
  • NXL -0.00
  • INHD 0.10
  • Stochastic Oscillator
  • NXL 18.75
  • INHD 39.62

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: